PETMED EXPRESS INC
Financial highlights
| Metric | FY March 31, 2025 | FY March 31, 2024 | FY March 31, 2023 | FY March 31, 2022 | FY March 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $227.0M | $274.1M | $247.6M | $272.3M | $303.6M |
| Gross profit | $69.1M | $84.8M | $76.5M | $76.9M | $84.3M |
| Operating income | -$1.5M | -$8.2M | $6.1M | $24.3M | $30.5M |
| Operating expenses | $70.7M | $92.9M | $70.5M | $52.7M | $53.8M |
| Cost of revenue | $157.8M | $189.3M | $171.1M | $195.3M | $219.3M |
| Cash from operations | $4.7M | $4.3M | $27.8M | $18.5M | $40.1M |
| Capital expenditure | $5.1M | $4.5M | $5.3M | $1.8M | $2.4M |
| Free cash flow | -$395,000 | -$194,000 | $22.5M | $16.7M | $37.6M |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | $1.2M | $0 | $0 | — | — |
| Total assets | $148.7M | $169.9M | $167.5M | $179.7M | $187.5M |
| Total liabilities | $63.6M | $73.2M | $57.5M | $56.2M | $46.2M |
Shares outstanding 21.4M · Free float 72.6%
Annual filing data through FY ended March 31, 2025; float as of July 3, 2026.